CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 786 of 870
Non-Antibody Products
Page 786 of 870
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Tafenoquine | An antimalarial agent; active against multidrug-resistant clinical isolate… | 50 mg | 30673-50 | More Info |
| Tafluprost | A prodrug form of tafluprost (free acid) and a PGF2α derivative; dec… | 1 mg | 10005440-1 | More Info |
| Tafluprost | A prodrug form of tafluprost (free acid) and a PGF2α derivative; dec… | 10 mg | 10005440-10 | More Info |
| Tafluprost | A prodrug form of tafluprost (free acid) and a PGF2α derivative; dec… | 25 mg | 10005440-25 | More Info |
| Tafluprost | A prodrug form of tafluprost (free acid) and a PGF2α derivative; dec… | 5 mg | 10005440-5 | More Info |
| Tafluprost-d4 | An internal standard for the quantification of tafluprost by GC- or LC-MS | 1 mg | 9002405-1 | More Info |
| Tafluprost-d4 | An internal standard for the quantification of tafluprost by GC- or LC-MS | 100 µg | 9002405-100 | More Info |
| Tafluprost-d4 | An internal standard for the quantification of tafluprost by GC- or LC-MS | 50 µg | 9002405-50 | More Info |
| Tafluprost-d4 | An internal standard for the quantification of tafluprost by GC- or LC-MS | 500 µg | 9002405-500 | More Info |
| Tafluprost ethyl amide | A derivative of tafluprost,, | 1 mg | 9000843-1 | More Info |
| Tafluprost ethyl amide | A derivative of tafluprost,, | 10 mg | 9000843-10 | More Info |
| Tafluprost ethyl amide | A derivative of tafluprost,, | 25 mg | 9000843-25 | More Info |
| Tafluprost ethyl amide | A derivative of tafluprost,, | 5 mg | 9000843-5 | More Info |
| Tafluprost ethyl ester | A form of tafluprost which may have increased lipid solubility compared to… | 1 mg | 11612-1 | More Info |
| Tafluprost ethyl ester | A form of tafluprost which may have increased lipid solubility compared to… | 10 mg | 11612-10 | More Info |
| Tafluprost ethyl ester | A form of tafluprost which may have increased lipid solubility compared to… | 5 mg | 11612-5 | More Info |
| Tafluprost (free acid) | An FP receptor agonist (Ki = 4 nM for the human receptor), a PGF2α d… | 1 mg | 10005439-1 | More Info |
| Tafluprost (free acid) | An FP receptor agonist (Ki = 4 nM for the human receptor), a PGF2α d… | 10 mg | 10005439-10 | More Info |
| Tafluprost (free acid) | An FP receptor agonist (Ki = 4 nM for the human receptor), a PGF2α d… | 25 mg | 10005439-25 | More Info |
| Tafluprost (free acid) | An FP receptor agonist (Ki = 4 nM for the human receptor), a PGF2α d… | 5 mg | 10005439-5 | More Info |
| Tafluprost (free acid)-d4 | An internal standard for the quantification of tafluprost (free acid) by G… | 1 mg | 9002406-1 | More Info |
| Tafluprost (free acid)-d4 | An internal standard for the quantification of tafluprost (free acid) by G… | 100 µg | 9002406-100 | More Info |
| Tafluprost (free acid)-d4 | An internal standard for the quantification of tafluprost (free acid) by G… | 50 µg | 9002406-50 | More Info |
| Tafluprost (free acid)-d4 | An internal standard for the quantification of tafluprost (free acid) by G… | 500 µg | 9002406-500 | More Info |
| T16A(inh)-A01 | An aminophenylthiazole that inhibits transient TMEM16A-mediated chloride c… | 10 mg | 18518-10 | More Info |
| T16A(inh)-A01 | An aminophenylthiazole that inhibits transient TMEM16A-mediated chloride c… | 5 mg | 18518-5 | More Info |
| T16A(inh)-A01 | An aminophenylthiazole that inhibits transient TMEM16A-mediated chloride c… | 50 mg | 18518-50 | More Info |
| TAK-041 | An agonist of GPR139; induces calcium mobilization in cells expressing hum… | 1 mg | 36108-1 | More Info |
| TAK-041 | An agonist of GPR139; induces calcium mobilization in cells expressing hum… | 10 mg | 36108-10 | More Info |
| TAK-041 | An agonist of GPR139; induces calcium mobilization in cells expressing hum… | 25 mg | 36108-25 | More Info |
| TAK-041 | An agonist of GPR139; induces calcium mobilization in cells expressing hum… | 5 mg | 36108-5 | More Info |
| TAK-063 | A potent inhibitor of PDE10A (IC50 = 0.3 nM); >15,000-fold selective for P… | 10 mg | 22208-10 | More Info |
| TAK-063 | A potent inhibitor of PDE10A (IC50 = 0.3 nM); >15,000-fold selective for P… | 25 mg | 22208-25 | More Info |
| TAK-063 | A potent inhibitor of PDE10A (IC50 = 0.3 nM); >15,000-fold selective for P… | 5 mg | 22208-5 | More Info |
| TAK-063 | A potent inhibitor of PDE10A (IC50 = 0.3 nM); >15,000-fold selective for P… | 50 mg | 22208-50 | More Info |
| TAK-220 | An orally bioavailable CCR5 antagonist; binds to human CCR5 (IC50 = 3.5 nM… | 1 mg | 28448-1 | More Info |
| TAK-242 | A TLR4 antagonist (IC50 = 0.68 µM in a SEAP assay); selectively bind… | 1 mg | 13871-1 | More Info |
| TAK-242 | A TLR4 antagonist (IC50 = 0.68 µM in a SEAP assay); selectively bind… | 10 mg | 13871-10 | More Info |
| TAK-242 | A TLR4 antagonist (IC50 = 0.68 µM in a SEAP assay); selectively bind… | 25 mg | 13871-25 | More Info |
| TAK-242 | A TLR4 antagonist (IC50 = 0.68 µM in a SEAP assay); selectively bind… | 5 mg | 13871-5 | More Info |
| TAK-285 | A dual inhibitor of EGFR and HER2 (IC50s = 23 and 17 nM, respectively); se… | 1 mg | 29157-1 | More Info |
| TAK-285 | A dual inhibitor of EGFR and HER2 (IC50s = 23 and 17 nM, respectively); se… | 10 mg | 29157-10 | More Info |
| TAK-285 | A dual inhibitor of EGFR and HER2 (IC50s = 23 and 17 nM, respectively); se… | 25 mg | 29157-25 | More Info |
| TAK-285 | A dual inhibitor of EGFR and HER2 (IC50s = 23 and 17 nM, respectively); se… | 5 mg | 29157-5 | More Info |
| TAK-385 | A GnRHR antagonist (IC50s = 0.33 and 0.32 nM for the human and monkey rece… | 1 mg | 29512-1 | More Info |
| TAK-385 | A GnRHR antagonist (IC50s = 0.33 and 0.32 nM for the human and monkey rece… | 10 mg | 29512-10 | More Info |
| TAK-385 | A GnRHR antagonist (IC50s = 0.33 and 0.32 nM for the human and monkey rece… | 25 mg | 29512-25 | More Info |
| TAK-385 | A GnRHR antagonist (IC50s = 0.33 and 0.32 nM for the human and monkey rece… | 5 mg | 29512-5 | More Info |
| TAK-599 | A prodrug of T-91825, a cephalosporin antibiotic; inhibits growth of S. pn… | 1 mg | 23696-1 | More Info |
| TAK-599 | A prodrug of T-91825, a cephalosporin antibiotic; inhibits growth of S. pn… | 10 mg | 23696-10 | More Info |
| TAK-599 | A prodrug of T-91825, a cephalosporin antibiotic; inhibits growth of S. pn… | 5 mg | 23696-5 | More Info |
| TAK-632 | A selective slow off-rate inhibitor of Raf kinases (IC50s = 8.3, 2.4, and… | 1 mg | 16285-1 | More Info |
| TAK-632 | A selective slow off-rate inhibitor of Raf kinases (IC50s = 8.3, 2.4, and… | 10 mg | 16285-10 | More Info |
| TAK-632 | A selective slow off-rate inhibitor of Raf kinases (IC50s = 8.3, 2.4, and… | 5 mg | 16285-5 | More Info |
| TAK-632 | A selective slow off-rate inhibitor of Raf kinases (IC50s = 8.3, 2.4, and… | 50 mg | 16285-50 | More Info |
| TAK-715 | An inhibitor of p38α MAPK (IC50 = 7.1 nM); selective for p38α… | 10 mg | 26170-10 | More Info |
| TAK-715 | An inhibitor of p38α MAPK (IC50 = 7.1 nM); selective for p38α… | 25 mg | 26170-25 | More Info |
| TAK-715 | An inhibitor of p38α MAPK (IC50 = 7.1 nM); selective for p38α… | 5 mg | 26170-5 | More Info |
| TAK-715 | An inhibitor of p38α MAPK (IC50 = 7.1 nM); selective for p38α… | 50 mg | 26170-50 | More Info |
| TAK-733 | A MEK1 inhibitor (IC50 = 3.2 nM); inhibits ERK phosphorylation in vitro (E… | 1 mg | 16998-1 | More Info |
| TAK-733 | A MEK1 inhibitor (IC50 = 3.2 nM); inhibits ERK phosphorylation in vitro (E… | 10 mg | 16998-10 | More Info |
| TAK-733 | A MEK1 inhibitor (IC50 = 3.2 nM); inhibits ERK phosphorylation in vitro (E… | 5 mg | 16998-5 | More Info |
| TAK-733 | A MEK1 inhibitor (IC50 = 3.2 nM); inhibits ERK phosphorylation in vitro (E… | 500 µg | 16998-500 | More Info |
| TAK-779 | An antagonist of CCR5, CCR2b, and CXCR3; inhibits CCR5 and CXCR3 (IC50s =… | 1 mg | 26744-1 | More Info |
| TAK-779 | An antagonist of CCR5, CCR2b, and CXCR3; inhibits CCR5 and CXCR3 (IC50s =… | 10 mg | 26744-10 | More Info |
| TAK-779 | An antagonist of CCR5, CCR2b, and CXCR3; inhibits CCR5 and CXCR3 (IC50s =… | 25 mg | 26744-25 | More Info |
| TAK-779 | An antagonist of CCR5, CCR2b, and CXCR3; inhibits CCR5 and CXCR3 (IC50s =… | 5 mg | 26744-5 | More Info |
| TAK-875 | A selective FFAR1 (GPR40) agonist (EC50 = 26 nM) that does not exhibit act… | 1 mg | 17335-1 | More Info |
| TAK-875 | A selective FFAR1 (GPR40) agonist (EC50 = 26 nM) that does not exhibit act… | 10 mg | 17335-10 | More Info |
| TAK-875 | A selective FFAR1 (GPR40) agonist (EC50 = 26 nM) that does not exhibit act… | 5 mg | 17335-5 | More Info |
| TAK-875 | A selective FFAR1 (GPR40) agonist (EC50 = 26 nM) that does not exhibit act… | 500 µg | 17335-500 | More Info |
| TAK-901 | A non-selective Aurora kinase inhibitor (IC50s = 3.1, 10, and 4.2 nM for A… | 1 mg | 23772-1 | More Info |
| TAK-901 | A non-selective Aurora kinase inhibitor (IC50s = 3.1, 10, and 4.2 nM for A… | 10 mg | 23772-10 | More Info |
| TAK-901 | A non-selective Aurora kinase inhibitor (IC50s = 3.1, 10, and 4.2 nM for A… | 25 mg | 23772-25 | More Info |
| TAK-901 | A non-selective Aurora kinase inhibitor (IC50s = 3.1, 10, and 4.2 nM for A… | 5 mg | 23772-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile